Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management / Martinelli, Giovanni; Iacobucci, Ilaria; Soverini, Simona; Cilloni, Daniela; Saglio, Giuseppe; Pane, Fabrizio; Baccarani, Michele. - In: HEMATOLOGICAL ONCOLOGY. - ISSN 0278-0232. - 24:4(2006), pp. 196-204. [10.1002/hon.792]

Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management

PANE, FABRIZIO;
2006

2006
Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management / Martinelli, Giovanni; Iacobucci, Ilaria; Soverini, Simona; Cilloni, Daniela; Saglio, Giuseppe; Pane, Fabrizio; Baccarani, Michele. - In: HEMATOLOGICAL ONCOLOGY. - ISSN 0278-0232. - 24:4(2006), pp. 196-204. [10.1002/hon.792]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/643005
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 27
social impact